Wells Fargo’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.75M | Sell |
189,636
-18,677
| -9% | -$442K | ﹤0.01% | 2637 |
|
|
2025
Q4 | $5.48M | Buy |
208,313
+31,679
| +18% | +$691K | ﹤0.01% | 2588 |
|
|
2025
Q3 | $3.02M | Buy |
176,634
+10,206
| +6% | +$146K | ﹤0.01% | 3008 |
|
|
2025
Q2 | $2.09M | Buy |
166,428
+66,119
| +66% | +$788K | ﹤0.01% | 3184 |
|
|
2025
Q1 | $1.19M | Sell |
100,309
-63,749
| -39% | -$869K | ﹤0.01% | 3536 |
|
|
2024
Q4 | $2.4M | Sell |
164,058
-13,352
| -8% | -$187K | ﹤0.01% | 3063 |
|
|
2024
Q3 | $2.23M | Buy |
177,410
+7,337
| +4% | +$79.9K | ﹤0.01% | 2979 |
|
|
2024
Q2 | $1.45M | Sell |
170,073
-68,614
| -29% | -$611K | ﹤0.01% | 3228 |
|
|
2024
Q1 | $2.51M | Buy |
238,687
+441
| +0.2% | +$4.9K | ﹤0.01% | 2796 |
|
|
2023
Q4 | $2.48M | Buy |
238,246
+46,616
| +24% | +$372K | ﹤0.01% | 2735 |
|
|
2023
Q3 | $1.21M | Sell |
191,630
-14,761
| -7% | -$109K | ﹤0.01% | 3191 |
|
|
2023
Q2 | $1.78M | Buy |
206,391
+121,524
| +143% | +$1.09M | ﹤0.01% | 3010 |
|
|
2023
Q1 | $767K | Sell |
84,867
-16,466
| -16% | -$144K | ﹤0.01% | 3566 |
|
|
2022
Q4 | $796K | Sell |
101,333
-7,593
| -7% | -$53.4K | ﹤0.01% | 3375 |
|
|
2022
Q3 | $670K | Buy |
108,926
+8,515
| +8% | +$51.3K | ﹤0.01% | 3503 |
|
|
2022
Q2 | $532K | Buy |
100,411
+18,705
| +23% | +$113K | ﹤0.01% | 3702 |
|
|
2022
Q1 | $535K | Buy |
81,706
+55,233
| +209% | +$492K | ﹤0.01% | 4355 |
|
|
2021
Q4 | $434K | Sell |
26,473
-53,271
| -67% | -$1.11M | ﹤0.01% | 4773 |
|
|
2021
Q3 | $2.32M | Sell |
79,744
-47,727
| -37% | -$1.59M | ﹤0.01% | 3531 |
|
|
2021
Q2 | $4.42M | Sell |
127,471
-477,598
| -79% | -$15.2M | ﹤0.01% | 2975 |
|
|
2021
Q1 | $19.1M | Buy |
605,069
+147,239
| +32% | +$5.98M | ﹤0.01% | 1706 |
|
|
2020
Q4 | $21.6M | Sell |
457,830
-17,517
| -4% | -$813K | 0.01% | 1505 |
|
|
2020
Q3 | $22.1M | Buy |
475,347
+68,762
| +17% | +$2.36M | 0.01% | 1345 |
|
|
2020
Q2 | $14.7M | Buy |
406,585
+131,565
| +48% | +$4.85M | ﹤0.01% | 1569 |
|
|
2020
Q1 | $9.75M | Sell |
275,020
-17,568
| -6% | -$719K | ﹤0.01% | 1682 |
|
|
2019
Q4 | $13.3M | Buy |
292,588
+258,421
| +756% | +$9.39M | ﹤0.01% | 1748 |
|
|
2019
Q3 | $847K | Sell |
34,167
-17,194
| -33% | -$431K | ﹤0.01% | 3968 |
|
|
2019
Q2 | $1.13M | Sell |
51,361
-11,646
| -18% | -$214K | ﹤0.01% | 3788 |
|
|
2019
Q1 | $1.02M | Buy |
63,007
+16,010
| +34% | +$248K | ﹤0.01% | 3865 |
|
|
2018
Q4 | $690K | Sell |
46,997
-42,797
| -48% | -$562K | ﹤0.01% | 4117 |
|
|
2018
Q3 | $1.41M | Buy |
89,794
+45,560
| +103% | +$652K | ﹤0.01% | 3700 |
|
|
2018
Q2 | $654K | Buy |
44,234
+41,148
| +1,333% | +$637K | ﹤0.01% | 4268 |
|
|
2018
Q1 | $37K | Sell |
3,086
-881
| -22% | -$9.53K | ﹤0.01% | 5654 |
|
|
2017
Q4 | $30K | Buy |
3,967
+576
| +17% | +$4.73K | ﹤0.01% | 5692 |
|
|
2017
Q3 | $27K | Buy |
3,391
+3,091
| +1,030% | +$24K | ﹤0.01% | 5636 |
|
|
2017
Q2 | $3K | Buy |
+300
| New | +$3.36K | ﹤0.01% | 6011 |
|
Other funds holding ZYME
EC
RCMNY
BI
PA
VCM
Wells Fargo's ZYME Position: Q1 2026 in Review
Wells Fargo reduced its Zymeworks (ZYME) stake by 9% in Q1 2026, selling an estimated $442K and leaving 189,636 shares worth $4.75M. The position accounts for ﹤0.01% of the portfolio, ranked #2637.
Wells Fargo first reported a position in ZYME in Q2 2017 and has held it in 36 quarters since. The position peaked at $22.1M in Q3 2020. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.
- Wells Fargo held 189,636 shares of Zymeworks worth $4.75M as of Q1 2026.
- Wells Fargo sold 18,677 Zymeworks shares in Q1 2026, an estimated $442K.
- Zymeworks made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #2637 holding.
- Wells Fargo first reported a position in Zymeworks in Q2 2017 and has held it in 36 quarters since.
- Wells Fargo's Zymeworks position peaked at $22.1M in Q3 2020.
- 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.